Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor

被引：14
|
作者：
Nishimura, T
Watanabe, K
Lee, U
Yahata, T
Ando, K
Kimura, M
Hiroyama, Y
Kobayashi, M
Herrmann, SH
Habu, S
机构：
[1] TOKAI UNIV,SCH MED,DEPT INFECT DIS,ISEHARA,KANAGAWA 25911,JAPAN
[2] TOKAI UNIV,SCH MED,DEPT MOLEC LIFE SCI,ISEHARA,KANAGAWA 25911,JAPAN
[3] DNARD INC,KAWASAKI,KANAGAWA 216,JAPAN
[4] GENET INST INC,CAMBRIDGE,MA 02140
来源：
IMMUNOLOGY LETTERS | 1995年 / 48卷 / 02期
关键词：
interleukin-12; tumor immunotherapy; primary tumor; mouse;
D O I：
10.1016/0165-2478(95)02448-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：149 / 152
页数：4
相关论文
共 50 条
  • [21] Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor alpha in mice
    Lasek, W
    Feleszko, W
    Golab, J
    Stoklosa, T
    Marczak, M
    Dabrowska, A
    Malejczyk, M
    Jakobisiak, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 22 - 22
  • [22] ADMINISTRATION OF SYSTEMIC OR LOCAL INTERLEUKIN-2 ENHANCES THE ANTITUMOR EFFECTS OF INTERLEUKIN-12 GENE-THERAPY
    PAPPO, I
    TAHARA, H
    ROBBINS, PD
    GATELY, MK
    WOLF, SF
    BARNEA, A
    LOTZE, MT
    JOURNAL OF SURGICAL RESEARCH, 1995, 58 (02) : 218 - 226
  • [23] In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model
    Wang, C
    Quevedo, ME
    Lannutti, BJ
    Gordon, KB
    Guo, DQ
    Sun, W
    Paller, AS
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (05) : 775 - 781
  • [24] AntiTumor Mechanism of Recombinant Murine Interleukin-12 Vaccine
    Yin, Xiaoling
    Yan, Xuexian
    Yang, Qinan
    Cao, Hui
    Liang, Houjie
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2010, 25 (03) : 263 - 268
  • [25] Interleukin-12: Murine models of a potent antitumor agent
    Brunda, MJ
    Luistro, L
    Rumennik, L
    Wright, RB
    Wigginton, JM
    Wiltrout, RH
    Hendrzak, JA
    Palleroni, AV
    INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 266 - 274
  • [26] In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma
    Verbik, DJ
    Stinson, WW
    Brunda, MJ
    Kessinger, A
    Joshi, SS
    CLINICAL & EXPERIMENTAL METASTASIS, 1996, 14 (03) : 219 - 229
  • [27] Interleukin-12 inhibits angiogenesis induced by human tumor cell lines in vivo
    Majewski, S
    Marczak, M
    Szmurlo, A
    Jablonska, S
    Bollag, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (05) : 1114 - 1118
  • [28] Synergistic effect of interleukin-15 and interleukin-12 on antitumor activity in a murine malignant pleurisy model
    Kimura, K
    Nishimura, H
    Matsuzaki, T
    Yokokura, T
    Nimura, Y
    Yoshikai, Y
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (02) : 71 - 77
  • [29] Synergistic effect of interleukin-15 and interleukin-12 on antitumor activity in a murine malignant pleurisy model
    Keiko Kimura
    Hitoshi Nishimura
    Takeshi Matsuzaki
    Teruo Yokokura
    Yuji Nimura
    Yasunobu Yoshikai
    Cancer Immunology, Immunotherapy, 2000, 49 : 71 - 77
  • [30] Antitumor effect of a self-amplyfing RNA expressing interleukin-12 in combination with in vivo electroporation
    Lasarte-Cia, A.
    Silva-Pilipich, N.
    J Lasarte, J.
    Smerdou, C.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A131 - A131
12345